公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2019 | A phase IV, randomized, multicenter, open-label trial comparing efficacy and systemic exposure for a standard weight-based dose versus a fixed dose of plerixafor in combination with G-CSF in patients with Non-Hodgkin’s lymphoma weighing ≤70 kg | Kuruvilla J.; Tzeng C.-H.; Cho S.-G.; Kim S.J.; JIH-LUH TANG ; Su Y.; Wu J.; Vargo R.; Cheverton P. | Bone Marrow Transplantation | 2 | 2 |